SCHM 📈 Schwab U.S. Mid-Cap - Overview

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US8085245087 • Mid-Cap Blend

SCHM: Financials, Industrials, Information Technology, Healthcare, Consumer Discretionary

The Schwab U.S. Mid-Cap ETF, listed on the NYSE ARCA under the ticker symbol SCHM, is designed to track the performance of the Dow Jones U.S. Mid-Cap Total Stock Market Index. This index is a subset of the broader Dow Jones U.S. Total Stock Market Index, focusing specifically on the mid-cap segment of the market. The mid-cap portion is defined as those components ranked 501-1000 by full market capitalization, providing a targeted exposure to this particular market segment. By tracking this index, the ETF offers investors a diversified portfolio of mid-cap stocks, which can be an attractive option for those seeking to tap into the potential of established companies that are still in a growth phase.

The Dow Jones U.S. Mid-Cap Total Stock Market Index is a float-adjusted market capitalization weighted index, meaning that the weights of the components are adjusted to reflect only the publicly available shares, excluding closely held or strategic shares. This approach aims to provide a more accurate representation of the market capitalization available for public investment. The ETF, in turn, will invest at least 90% of its net assets in securities that are included in the index, ensuring a high level of consistency with the underlying index's performance. This investment strategy allows the fund to closely track the index's returns, providing investors with a reliable and efficient way to gain exposure to the U.S. mid-cap market.

As an exchange-traded fund (ETF), the Schwab U.S. Mid-Cap ETF offers the benefits of transparency, flexibility, and cost-efficiency. Listed on the NYSE ARCA, it can be bought and sold throughout the trading day, allowing investors to quickly respond to market opportunities. With its domicile in the United States and ISIN of US8085245087, the fund is subject to U.S. regulatory requirements, providing an additional layer of investor protection. The ETF falls under the mid-cap blend category, indicating that it does not have a specific style bias, such as growth or value, but instead seeks to represent the overall mid-cap market segment. For more information, investors can visit the company's website at http://www.schwabfunds.com.

Additional Sources for SCHM ETF

SCHM ETF Overview

Market Cap in USD 11,276m
Category Mid-Cap Blend
TER 0.04%
IPO / Inception 2011-01-13

SCHM ETF Ratings

Growth 5y 62.6%
Fundamental -
Dividend 53.6%
Rel. Strength Industry -24.9
Analysts -
Fair Price Momentum 28.74 USD
Fair Price DCF -

SCHM Dividends

Dividend Yield 12m 2.58%
Yield on Cost 5y 4.23%
Annual Growth 5y 4.66%
Payout Consistency 84.2%

SCHM Growth Ratios

Growth Correlation 3m 5.9%
Growth Correlation 12m 86.4%
Growth Correlation 5y 71.2%
CAGR 5y 10.48%
CAGR/Mean DD 5y 1.26
Sharpe Ratio 12m 0.97
Alpha -9.22
Beta 1.14
Volatility 17.06%
Current Volume 809.7k
Average Volume 20d 1115.4k
What is the price of SCHM stocks?
As of January 18, 2025, the stock is trading at USD 28.82 with a total of 809,700 shares traded.
Over the past week, the price has changed by +4.34%, over one month by +0.45%, over three months by +2.25% and over the past year by +21.15%.
Is Schwab U.S. Mid-Cap a good stock to buy?
Yes. Based on ValueRay Analyses, Schwab U.S. Mid-Cap (NYSE ARCA:SCHM) is currently (January 2025) a good stock to buy. It has a ValueRay Growth Rating of 62.59 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SCHM as of January 2025 is 28.74. This means that SCHM is currently overvalued and has a potential downside of -0.28%.
Is SCHM a buy, sell or hold?
Schwab U.S. Mid-Cap has no consensus analysts rating.
What are the forecast for SCHM stock price target?
According to ValueRays Forecast Model, SCHM Schwab U.S. Mid-Cap will be worth about 32.1 in January 2026. The stock is currently trading at 28.82. This means that the stock has a potential upside of +11.38%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 32.1 11.4%